Change Control Automation and Impact Assessment Workflows in eQMS The effective management of change control processes is integral to maintaining compliance with regulatory standards, specifically under guidelines established by the U.S. FDA, such as 21 CFR Part 11. As the pharmaceutical industry increasingly adopts Quality Management Systems (QMS) that integrate automation and electronic features, it is critical to understand how Change Control Automation and Impact Assessment workflows contribute to this regulatory landscape. This article serves as a step-by-step tutorial for professionals in the pharmaceutical sector and related fields, focusing on eQMS validation, CAPA workflows, and best practices for achieving operational…

Case Study: Turning Around a Weak QMS Using eQMS and Automation In the highly regulated pharmaceutical industry, the quality management system (QMS) stands as the backbone of compliance and operational efficiency. A weakened QMS can lead to significant regulatory hurdles, operational inefficiencies, and a detriment to overall product quality. In this tutorial, we present a case study illustrating how an effective eQMS and automation can not only remedy a deficient QMS but also enhance compliance with 21 CFR Part 11 and streamline various workflows, including Corrective and Preventive Action (CAPA) processes. Understanding Quality Management Systems The QMS is a structured…

Training Quality Teams on eQMS Usability, Workflows and Compliance Introduction to eQMS in FDA-Regulated Environments The transition from traditional Quality Management Systems (QMS) to electronic Quality Management Systems (eQMS) has become increasingly necessary in FDA-regulated environments. The FDA’s emphasis on data integrity and compliance has driven organizations to adopt eQMS solutions. Effective training of quality teams on eQMS usability, workflows, and compliance is crucial to ensure the system enhances quality control processes, particularly under 21 CFR Part 11, which oversees electronic records and signatures. This tutorial aims to provide a comprehensive, step-by-step understanding of how to train quality teams in…

Building a Business Case for QMS and Workflow Automation in GMP Plants In the landscape of pharmaceutical manufacturing, companies face mounting pressure to enhance quality, efficiency, and compliance within their operations. The implementation of a Quality Management System (QMS) and the automation of related workflows stand out as prime solutions to meet these challenges. This tutorial aims to guide regulatory professionals through the process of building a business case for QMS and workflow automation in Good Manufacturing Practice (GMP) environments, especially in the context of US FDA regulations. 1. Understanding the Basics of Quality Management Systems (QMS) The foundation of…

Vendor Qualification and SaaS eQMS Due Diligence for GxP Use Vendor Qualification and SaaS eQMS Due Diligence for GxP Use Introduction to eQMS and Vendor Qualification In the pharmaceutical and biotechnology landscapes, the qualification of vendors, particularly those providing electronic Quality Management Systems (eQMS), is critical for ensuring compliance with Good Practice (GxP) regulations. As organizations increasingly embrace digital transformation and automation in their quality management systems, understanding the necessary steps to ensure regulatory compliance becomes paramount. This tutorial guides professionals through the regulatory framework surrounding vendor qualification and eQMS due diligence, emphasizing the importance of implementing robust systems that…

Best Practices for Multi-Site Rollout of a Validated eQMS In today’s FDA-regulated environments, organizations in the pharmaceutical industry must ensure compliance with rigorous regulations while maximizing efficiency through technology. The implementation of an electronic Quality Management System (eQMS) serves as a fundamental element in achieving these goals. This article provides a step-by-step regulatory tutorial on the best practices for the multi-site rollout of a validated eQMS. It will cover the necessary elements for eQMS validation, QMS automation, CAPA workflows, and integration with 21 CFR Part 11 compliance, crucial for maintaining a quality management system across diversified operations. Understanding eQMS Validation…

Data Integrity Controls for Process Data Historians and SCADA Systems Data Integrity Controls for Process Data Historians and SCADA Systems In the pharmaceutical and biotechnology sectors, ensuring data integrity within digital systems—such as data historians, SCADA, DCS, and PLC—is paramount for regulatory compliance and maintaining product quality. This tutorial provides a structured approach to establishing data integrity controls in these automated environments, focusing on relevant aspects of 21 CFR Part 11. This guidance is intended for professionals involved in regulatory affairs, clinical operations, and quality management, helping them navigate the complexities of validation and compliance. Understanding the Role of Data…

PLC Software Validation and Change Management Under FDA Regulations PLC Software Validation and Change Management Under FDA Regulations In the highly regulated environments of the pharmaceutical and biotech industries, ensuring compliance with FDA regulations, particularly with regards to automation systems, is of paramount importance. This guide provides a step-by-step tutorial on the validation of PLC software and effective change management practices, aligning with 21 CFR Part 11 guidelines for process control. Understanding the Importance of PLC Software Validation Programmable Logic Controllers (PLCs) are integral components in automation systems, particularly when it comes to Good Manufacturing Practice (GMP) process control in…

Understanding 21 CFR Part 11 Expectations for Electronic Process Control Records The regulation of electronic records and signatures is a critical component of the FDA’s oversight of pharmaceutical manufacturing and clinical research. 21 CFR Part 11, titled “Electronic Records; Electronic Signatures,” governs how electronic systems can be used in FDA-regulated environments. This guide provides a comprehensive overview of 21 CFR Part 11 expectations for electronic process control records, focusing on data historian validation, SCADA, DCS, and PLC systems utilized within Good Manufacturing Practice (GMP) environments. Introduction to 21 CFR Part 11 In the context of modern automation systems, understanding 21…

Common 483 Findings on Automation and Control Systems in FDA Inspections In the ever-evolving landscape of FDA-regulated environments, automation and control systems play a critical role in ensuring compliance with Good Manufacturing Practices (GMP). The rise of digital validation systems, including data historians, SCADA systems, DCS, and PLCs, has introduced new complexities in regulatory oversight. Understanding common findings during FDA inspections can help pharmaceutical professionals preemptively address issues related to automation. This comprehensive guide will detail the common 483 findings regarding automation and control systems, emphasizing best practices for enhancing compliance. Understanding 21 CFR Part 11 and Its Relevance to…